Article information
Full text is only aviable in PDF
REFERENCES
[3]
JM Longini, JS Koopman, AS Monto, JP Fox.
Estimating household and community transmission parameters for influenza.
Am J Epidemiol., 115 (1982), pp. 736-751
[4]
JP Fox, CE Hall, MK Cooney, HM Foy.
Influenza virus infection in Seattle families, 1975–1979. Study design, methods and the occurrence of infections by time and age.
Am J Epidemiol., 116 (1982), pp. 212-227
[5]
Prevention and control of influenza: recommendations of the Advisory Committee on Immunization Practices (ACIP).
MMWR, 51 (2002), pp. 1-31
[6]
Influenza.
Red book: report of the Committee on Infectious Diseases, 24th ed., pp. 307-315
[7]
KG Nicholson, R Snacken, AM Palache.
Influenza immunization polices in Europe and the United States.
Vaccine, 13 (1995), pp. 365-368
[8]
Committee on Infectious Diseases 2002–2003.
Recommended childhood and adolescent immunization schedule: United States, 2003.
Pediatrics, 111 (2003), pp. 212
[9]
Comité Asesor de Vacunas de la AEP.
Calendario vacunal de la Asociación Española de Pediatría 2003.
An Pediatr (Barc), 58 (2003), pp. 257-262
[10]
AM LeVine, V Koeningsknecht, JM Stark.
Decreased pulmonary clearance of S. pneumoniae following influenza A infection in mice.
J Virol Methods, 94 (2001), pp. 173-186
[11]
A Malhotra, LR Krilov.
Influenza and respiratory syncytial virus. Update on infection, management and prevention.
Pediatr Clin North Am, 47 (2000), pp. 353-372
[12]
N Cox, K Subbarao.
Influenza.
Lancet, 354 (1999), pp. 1277-1282
[13]
WP Glezen.
Prevention of acute otitis media by prophylaxis and treatment of influenza virus infections.
Vaccine, 19 (2000), pp. 56-58
[14]
KL O'Brien, MI Walters, J Sellman, P Quinlisk, H Regnery, B Schwartz, et al.
Severe pneumococcal pneumonia in previously healthy children: the role of preceding influenza infection.
Clin Infect Dis, 30 (2000), pp. 784-789
[15]
SB Mossad.
Underused options for preventing and treating influenza.
Cleveland Clin J Med, 66 (1999), pp. 19-23
[16]
WP Glezen, LH Taber, A FranK, WC Gruber, PA Piedra.
Influenza virus infections in infants.
Pediatr Infect Dis J, 16 (1997), pp. 1065-1068
[17]
T Heikkinen, M Thint, T Chonmaitree.
Prevalence of various respiratory viruses in the middle ear during acute otitis media.
N Engl J Med, 340 (1999), pp. 260-264
[18]
T Heikkinen, O Ruuskanen, M Waris, T Ziegler, M Arola, P Halonen.
Influenza vaccination in the prevention of acute otitis media in children.
Am J Dis Child, 145 (1991), pp. 445-448
[19]
DA Clemments, L Langdon, C Bland, E Walter.
Influenza A vaccine decreases the incidence of otitis media in 6- to 30-month-old children in day care.
Arch Pediatr Adolesc Med, 149 (1995), pp. 1113-1117
[20]
RB Belshe, PM Mendelman, J Treanor, J King, WC Gruber, P Piedra, et al.
The efficacy of live attenuated, cold-adapted, trivalent, intranasal influenza virus vaccines in children.
N Engl J Med, 338 (1998), pp. 1405-1412
[21]
T Heikkinen.
The role of respiratory viruses in otitis media.
Vaccine, 19 (2000), pp. 51-55
[22]
M Eriksson, R Bennet, A Nilsson.
Wheezing following lower respiratory tract infections with respiratory syncytial virus and influenza A in infancy.
Pediatr Allergy Immunol, 11 (2000), pp. 193-197
[23]
KM Neuzil, PF Wright, EF Mitchel Jr, MR Griffin.
The burden of influenza illness in children with asthma and other chronic medical conditions.
J Pediatr, 137 (2000), pp. 856-864
[24]
P Kramarz, F de Stefano, PM Gargiullo, RT Chen, TA Lieu, El Davis, et al.
Vaccine Safety Datalink Team. Does influenza vaccination prevent asthma exacerbations in children?.
J Pediatr, 138 (2001), pp. 306-310
[25]
R Dagan, CB Hall.
Influenza A virus infection imitating bacterial sepsis in early infancy.
Pediatr Infect Dis, 3 (1984), pp. 218-221
[26]
HT Kao, YC Huang, TY Lin.
Influenza A virus infection in infants.
J Microbiol Immunol Infect, 33 (2000), pp. 105-108
[27]
T Togashi, Y Matsuzono, M Narita.
Epidemiology of influenza associated encephalitis-encephalopathy in Hokkaido, the northernmost island of Japan.
Pediatr Int, 42 (2000), pp. 192-196
[28]
L Simonsen, MJ Clarke, GD Williamson, DF Stroup, NH Arden, LB Schonberger.
The impact of influenza epidemics on mortality: introducing a severity index.
Am J Public Health, 87 (1997), pp. 1944-1950
[29]
RG Fisher, WC Gruber, KM Edwards, GW Reed, SJ Tollefson, JM Thompson, et al.
Twenty years of outpatient respiratory syncytial virus infections a framework for vaccine efficacy trial.
Pediatrics, 99 (1997), pp. E7
[30]
RB Couch, JA Kasel, WP Glezen, et al.
Influenza: its control in persons and populations.
J Infect Dis, 153 (1986), pp. 431-440
[31]
WP Glezen, A Paredes, LH Taber.
Influenza in children: relationship to other respiratory agents.
JAMA, 243 (1980), pp. 1345-1349
[32]
WP Glezen.
Considerations of the risk of influenza in children and indications for prophylaxis.
Rev Infect Dis, 2 (1980), pp. 408-420
[33]
JP Mullooly, WH Barker.
Impact of type A influenza in children: a retrospective study.
Am J Public Health, 72 (1982), pp. 1008-1016
[34]
KM Neuzil, BG Mellen, PF Wright, EF Mitchel Jr, MR Griffin.
The effect of influenza on hospitalizations, outpatient visits, and courses of antibiotics in children.
N Engl J Med, 342 (2000), pp. 225-231
[35]
GF Hayden, H Frayha, H Kattan, I Mogarri.
Structured guidelines for the use of influenza vaccine among children with chronic pulmonary disorders.
Pediatr infect Dis J, 14 (1995), pp. 895-899
[36]
HS Izurieta, WW Thompson, P Kramarz, DK Shay, RL Davis, F de Stefano, et al.
Influenza and the rates of hospitalization for respiratory disease among infants and young children.
N Engl J Med, 342 (2000), pp. 232-239
[37]
N Sugaya, K Mitamura, M Nirasawa, K Takahashi.
The impact of winter epidemics of influenza and respiratory syncytial virus on paediatric admissions to an urban general hospital.
J Med Virol, 60 (2000), pp. 102-106
[38]
AS Monto, FM Davenport, JA Naiper, T Francis Jr.
Modification of an outbreak of influenza in Tecumseh, Michigan by vaccination of schoolchildren.
J Infect Dis, 122 (1970), pp. 16-25
[39]
TA Reichert, N Sugaya, DS Fedson, P Glezen, L Simonsen, M Tashiro.
The Japanese experience with vaccinating schoolchildren against influenza.
N Engl J Med, 344 (2001), pp. 889-896
[40]
T Tango, H Santomi, H Mori, K Yamaoka.
Efficacy of influenza vaccination: the detection of a seeming efficacy.
Nippon Koshu Eisei, 37 (1990), pp. 967-978
[41]
Centers for Disease Control and Prevention.
Epidemiology and prevention of vaccine-preventable diseases, 5th ed., pp. 247-264
[42]
American Academy of Pediatrics.
Recommended childhood and adolescent immunization schedule: United States, 2003.
Pediatrics, 111 (2003), pp. 212
[43]
JR de Juanes, MP Arrazola.
Vacunas inactivadas de la gripe.
Vacunas: Investigación y Práctica, 3 (2002), pp. 47-50
[44]
Centers for Disease Control and Prevention.
Prevention and control of influenza: recommendation of the Advisory Committee on Immunization Practice (ACIP).
MMWR, 51 (2002),
[45]
Centers for Disease Control and Prevention.
Questions and answers on influenza vaccine and Guillen-Barre syndrome (GBS).
[46]
J Reina.
Vacunas atenuadas (cold-adapted) de la gripe.
Vacunas: Investigación y Práctica, 3 (2002), pp. 51-61
[48]
G Alenxandrova, A Smorodintsev.
Obtaining of an additionally attenuated vaccinating cryophilic influenza strain.
Rev Roum Inframicrobiol, 2 (1965), pp. 179-189
[49]
L Rudenko, A Ramires, M Barro.
Vaccination properties of live recombinant influenza types A and B used separately and in combination in children of 3–14 years.
Vorp Virusol, 36 (1991), pp. 474
[50]
L Rudenko, A Slepushkin, A Monto.
Efficacy of live attenuated and inactivated influenza vaccine in schoolchildren and their unvaccinated contacts in Novgorod. Rusia.
J Infect Dis, 168 (1993), pp. 881-887
[52]
HF Maasab, DC Deborde.
Development and characterization of cold-adapted viruses for use as live virus vaccines.
Vaccine, 3 (1985), pp. 355-369
[53]
J Ruiz Contreras.
Vacuna intranasal frente a la gripe.
Vacunas 2001, pp. 173-179
[54]
RB Belshe, WG Gruber, PM Mendelman, HB Mehta, K Mahmood, K Reisinger, et al.
Correlates of immune protection induced by live, attenuated, cold-adapted, trivalent intranasal influenza virus vaccine.
J Infect Dis, 181 (2000), pp. 1133-1137
[55]
FDA.
First nasal mist flu vaccine approved. FDA News.
[56]
BR Murphy, DL Nelson, PF Wryght, EL Tiemey, MA Phelan, RM Chanock.
Secretory and systemic immunological response in children infected with live attenuated influenza A virus vaccines.
Infecc Immun, 36 (1982), pp. 1102-1108
Copyright © 2004. Sociedad Española de Neumología y Cirugía Torácica (SEPAR)
